LONGBIO-B(01779) has been included in the stock lists of the Shanghai-Hong Kong Stock Connect and the Shenzhen-Hong Kong Stock Connect.
Tianchen Biotechnology-B (01779) announced that, according to the notice on the adjustment of eligible securities under the Shanghai-Hong Kong Stock Connect issued by the Shanghai Stock Exchange on September 4, 2026, and the announcement on the adjustment of the Hong Kong Stock Connect eligible securities list under the Shenzhen-Hong Kong Stock Connect issued by the Shenzhen Stock Exchange on September 7, 2026, the company has been included in the list of eligible securities under the Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect programs, effective from September 7, 2026. After being included in the eligible securities list, qualified investors in mainland China will be able to directly trade the company's shares through the Shanghai Stock Exchange and Shenzhen Stock Exchange.
LONGBIO-B (01779) announced that, according to the notice issued by the Shanghai Stock Exchange on September 4, 2026, regarding adjustments to the eligible securities under the Stock Connect program, and the announcement made by the Shenzhen Stock Exchange on September 7, 2026, concerning adjustments to the list of eligible securities under the Shenzhen-Hong Kong Stock Connect program, the company has been included in the list of eligible securities for both Stock Connect programs, effective from September 7, 2026. After the company's shares are included in the list of eligible securities, qualified investors in mainland China will be able to buy and sell shares directly through the Shanghai and Shenzhen Stock Exchanges.
The Board of Directors believes that the inclusion of the shares in the trading mechanisms of the Stock Connect programs demonstrates the market's high recognition of the investment value and growth prospects of the company. The company expects that being included in the list of eligible securities will further help to expand the shareholder base, attract more long-term institutional investors, increase the trading liquidity of the shares, and lay a solid foundation for the company's long-term development, thereby enhancing the company's investment value and reputation in the capital markets.
Related Articles

Jiangsu Tongxingbao Intelligent Transportation Technology (301339.SZ) plans to change its stock abbreviation to Su Jiang Shuzhi.

MICOT PHARMA-B (02335) has been included in the stock connection mechanism (Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect) stock list.

DEKON AGR (02419) has been awarded the 2026 Growth Value Golden Bull Award for solidifying long-term value through technological innovation.
Jiangsu Tongxingbao Intelligent Transportation Technology (301339.SZ) plans to change its stock abbreviation to Su Jiang Shuzhi.

MICOT PHARMA-B (02335) has been included in the stock connection mechanism (Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect) stock list.

DEKON AGR (02419) has been awarded the 2026 Growth Value Golden Bull Award for solidifying long-term value through technological innovation.

RECOMMEND





